You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨諾誠健華-B(9969.HK)升超8%續創新高 8日累計漲幅超41%
格隆匯 04-06 13:32
格隆匯4月6日丨次新股諾誠健華-B(9969.HK)自上市以來走勢強勢,目前連續上漲8日累計漲幅超41%。現報13.9港元,漲8.59%,暫成交1.1億港元,最新總市值174億港元。公司是一家處於臨牀階段的生物醫藥公司,其中主力產品奧布替尼(ICP-022)是一款潛在Best in Class的新型BTK抑制劑。招股書顯示,全球、中國的BTK抑制劑市場持續增長,預計中國BTK抑制劑市場2019-2023年按複合年增長率89.2%增長,2023年市場規模將達10億美元。值得一提的是,諾誠健華成為了首家在港股市場採用“雲敲鑼”上市的公司。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account